Companies / Orlucent
Orlucent
Company
Orlucent has developed a handheld fluorescent molecular imaging system to non-invasively evaluate early tissue remodeling that signals the likelihood of a mole's transition to melanoma.
Orlucent has 1 investor on file, among them Emergent Medical Partners. Its site was last checked 7 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from Emergent Medical Partners
16 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (81%), Industrial & Manufacturing (13%), Space & Defense (6%).
See Emergent Medical Partners' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Orlucent and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Emergent Medical Partners adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/orlucent.com/investors
# also
GET /v1/companies/orlucent.com
GET /v1/companies/orlucent.com/news